Kentucky Retirement Systems Insurance Trust Fund Sells 364 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Kentucky Retirement Systems Insurance Trust Fund decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.8% in the 1st quarter, Holdings Channel reports. The firm owned 4,288 shares of the company’s stock after selling 364 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Henry Schein were worth $324,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in HSIC. SG Americas Securities LLC raised its holdings in Henry Schein by 135.1% during the 4th quarter. SG Americas Securities LLC now owns 9,734 shares of the company’s stock worth $737,000 after purchasing an additional 5,593 shares during the last quarter. Raymond James & Associates raised its holdings in Henry Schein by 672.5% during the 4th quarter. Raymond James & Associates now owns 153,046 shares of the company’s stock worth $11,587,000 after purchasing an additional 133,233 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Henry Schein by 13.3% during the 4th quarter. Assenagon Asset Management S.A. now owns 58,979 shares of the company’s stock worth $4,465,000 after purchasing an additional 6,934 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $39,000. Finally, Caprock Group LLC acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $679,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC traded down $0.49 during midday trading on Monday, hitting $71.82. 483,779 shares of the company traded hands, compared to its average volume of 1,101,949. The stock has a 50-day moving average of $68.08 and a 200-day moving average of $71.83. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The firm has a market cap of $9.20 billion, a P/E ratio of 24.43, a PEG ratio of 1.78 and a beta of 0.87. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. During the same period in the prior year, the business posted $1.21 earnings per share. The company’s revenue was up 3.7% on a year-over-year basis. As a group, sell-side analysts predict that Henry Schein, Inc. will post 5.16 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on HSIC. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from $81.00 to $92.00 in a research report on Monday, July 22nd. Piper Sandler reaffirmed an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Evercore ISI reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. Finally, Barrington Research reissued an “outperform” rating and issued a $92.00 price target on shares of Henry Schein in a research report on Friday, July 5th. One analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $81.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.